pharmaceutical investing Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome
